We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALA icon
3301
KALA BIO
KALA
$14.2M
$99K ﹤0.01%
+282
New +$99.8K
FTH
3302
Faeth Therapeutics
FTH
$631M
$99K ﹤0.01%
7,175
+2,985
+71% +$40.7K
AEYE icon
3303
AudioEye
AEYE
$72.2M
$98K ﹤0.01%
18,100
+4,500
+33% +$20.4K
INKT icon
3304
MiNK Therapeutics
INKT
$54.8M
$98K ﹤0.01%
9,204
+3,434
+60% +$35.8K
ITRM
3305
DELISTED
Iterum Therapeutics
ITRM
$98K ﹤0.01%
49,922
+3,000
+6% +$3.72K
VSTA
3306
DELISTED
Vasta Platform
VSTA
$98K ﹤0.01%
22,000
+500
+2% +$2.04K
DPSI
3307
DELISTED
DecisionPoint Systems, Inc.
DPSI
$98K ﹤0.01%
15,600
+5,125
+49% +$28.4K
MATH icon
3308
Metalpha Technology Holding
MATH
$40.8M
$97K ﹤0.01%
44,600
-400
-0.9% -$606
SRZN icon
3309
Surrozen
SRZN
$251M
$97K ﹤0.01%
10,326
+2,019
+24% +$14.1K
TNXP icon
3310
Tonix Pharmaceuticals
TNXP
$186M
$97K ﹤0.01%
75
+5
+7% +$8.05K
ORKA
3311
Oruka Therapeutics
ORKA
$5.94B
$97K ﹤0.01%
4,775
+542
+13% +$12.2K
FUSN
3312
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$96K ﹤0.01%
+10,000
New +$48.6K
AQB icon
3313
AquaBounty Technologies
AQB
$5.51M
$95K ﹤0.01%
33,420
+1,245
+4% +$3.59K
REFR icon
3314
Research Frontiers
REFR
$16.3M
$95K ﹤0.01%
94,400
+70,500
+295% +$73.2K
APVO icon
3315
Aptevo Therapeutics
APVO
$5.07M
$94K ﹤0.01%
+1
New +$142K
FSEA icon
3316
First Seacoast Bancorp
FSEA
$80.1M
$93K ﹤0.01%
+12,132
New +$83.2K
TENX icon
3317
Tenax Therapeutics
TENX
$498M
$93K ﹤0.01%
+4,252
New +$102K
BHAT
3318
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
$92K ﹤0.01%
18
+8
+80% +$50K
CARV
3319
DELISTED
Carver Bancorp
CARV
$92K ﹤0.01%
46,900
+11,300
+32% +$19.5K
NRXP icon
3320
NRX Pharmaceuticals
NRXP
$132M
$92K ﹤0.01%
20,048
+3,670
+22% +$12.1K
RSVR
3321
Reservoir Media
RSVR
$678M
$92K ﹤0.01%
+12,848
New +$78.2K
PDYN icon
3322
Palladyne AI
PDYN
$278M
$92K ﹤0.01%
127,078
+55,800
+78% +$36.3K
EXAI
3323
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$92K ﹤0.01%
14,322
-43,678
-75% -$247K
EVA
3324
DELISTED
Enviva Inc.
EVA
$92K ﹤0.01%
+92,200
New +$256K
SNCE
3325
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$92K ﹤0.01%
17,145
-1,134
-6% -$6.99K

Similar funds

Renaissance Technologies's Q4 2023 Portfolio in Review

As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
  • Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.